Literature DB >> 10923034

The thermolabile variant 677C-->T can further reduce activity when expressed in cis with severe mutations for human methylenetetrahydrofolate reductase.

P Goyette1, R Rozen.   

Abstract

Methylenetetrahydrofolate reductase (MTHFR) catalyses the reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a carbon donor for homocysteine remethylation to methionine. Severe MTHFR deficiency is associated with hyperhomocysteinemia and homocystinuria. These patients show a wide variety of neurological and vascular symptoms, with variable age of onset. Residual enzyme activity is usually less than 20% of control values, and correlates reasonably well with age of onset of symptoms. A milder deficiency of MTHFR, with 30%-50% residual enzyme activity and increased enzyme thermolability, has been described as a risk factor for vascular disease and for neural tube defects. In earlier work, we isolated the human cDNA for MTHFR, and reported 14 mutations in severe MTHFR deficiency, as well as a common 677C-->T missense mutation (Ala-->Val) that encodes the thermolabile MTHFR. This variant has also been observed in some patients with severe MTHFR deficiency, in cis with their severe mutations. We report here the in vitro expression of seven severe MTHFR mutations in a bacterial expression system; six of these were expressed in cis with the Val allele to mimic the situation in the patients. We show that three of these constructs have significantly reduced enzyme activity (<10% of control); the presence of the thermolabile variant in these patients in cis is unlikely to affect enzyme function since activity is already low. One mutation causes a dramatic increase in activity when it is expressed in cis with the Ala allele, but is associated with extreme lability when in cis with the Val allele. Three mutations cause moderate decreases in enzyme activity, with a further decrease in activity when they are in cis with the Val allele. We hypothesize that deleterious mutations which alter stability may be compromised to a greater degree when the thermolabile variant is present on the same allele. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10923034     DOI: 10.1002/1098-1004(200008)16:2<132::AID-HUMU5>3.0.CO;2-T

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  12 in total

1.  Functional characterization of missense mutations in severe methylenetetrahydrofolate reductase deficiency using a human expression system.

Authors:  Patricie Burda; Terttu Suormala; Dorothea Heuberger; Alexandra Schäfer; Brian Fowler; D Sean Froese; Matthias R Baumgartner
Journal:  J Inherit Metab Dis       Date:  2016-10-14       Impact factor: 4.982

2.  Is there any genetic predisposition of MMP-9 gene C1562T and MTHFR gene C677T polymorphisms with essential hypertension?

Authors:  Aysegul Bayramoglu; Meral Urhan Kucuk; Halıl Ibrahim Guler; Okay Abaci; Yunus Kucukkaya; Ertugrul Colak
Journal:  Cytotechnology       Date:  2013-11-21       Impact factor: 2.058

Review 3.  Polymorphisms in 1-carbon metabolism, epigenetics and folate-related pathologies.

Authors:  Patrick J Stover
Journal:  J Nutrigenet Nutrigenomics       Date:  2012-02-22

4.  MTHFR methylation moderates the impact of smoking on DNA methylation at AHRR for African American young adults.

Authors:  Steven R H Beach; Man Kit Lei; Mei Ling Ong; Gene H Brody; Meeshanthini V Dogan; Robert A Philibert
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-04-24       Impact factor: 3.568

Review 5.  A literature review of MTHFR (C677T and A1298C polymorphisms) and cancer risk.

Authors:  Muzeyyen Izmirli
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

6.  Liver transplantation for aHUS: still needed in the eculizumab era?

Authors:  Rosanna Coppo; Roberto Bonaudo; R Licia Peruzzi; Alessandro Amore; Andrea Brunati; Renato Romagnoli; Mauro Salizzoni; Miriam Galbusera; Eliana Gotti; Erica Daina; Marina Noris; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2015-11-24       Impact factor: 3.714

Review 7.  Systematic meta-analyses and field synopsis of genetic association studies in colorectal adenomas.

Authors:  Zahra Montazeri; Evropi Theodoratou; Christine Nyiraneza; Maria Timofeeva; Wanjing Chen; Victoria Svinti; Shanya Sivakumaran; Gillian Gresham; Laura Cubitt; Luis Carvajal-Carmona; Monica M Bertagnolli; Ann G Zauber; Ian Tomlinson; Susan M Farrington; Malcolm G Dunlop; Harry Campbell; Julian Little
Journal:  Int J Epidemiol       Date:  2015-10-07       Impact factor: 7.196

8.  Methotrexate-induced decrease in embryonic 5-methyl-tetrahydrofolate is irreversible with leucovorin supplementation.

Authors:  Tseng-Ting Kao; Gang-Hui Lee; Chi-Chang Fu; Bing-Hung Chen; Li-Ting Chen; Tzu-Fun Fu
Journal:  Zebrafish       Date:  2013-06-12       Impact factor: 1.985

9.  Genome-wide significant predictors of metabolites in the one-carbon metabolism pathway.

Authors:  Aditi Hazra; Peter Kraft; Ross Lazarus; Constance Chen; Stephen J Chanock; Paul Jacques; Jacob Selhub; David J Hunter
Journal:  Hum Mol Genet       Date:  2009-09-10       Impact factor: 6.150

10.  More severe toxicity of genetic polymorphisms on MTHFR activity in osteosarcoma patients treated with high-dose methotrexate.

Authors:  Lu Xie; Wei Guo; Yi Yang; Tao Ji; Jie Xu
Journal:  Oncotarget       Date:  2017-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.